HLA-DR3 and HLA-DR4 Positivity in Young-Onset Diabetes in Bangladesh: A Pilot Case–Control Study
Bangladesh Journal of Endocrinology and Metabolism · 2026-09 · 5 (3) · 320-327
DOI: 10.4103/bjem.bjem_32_26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bangladesh Journal of Endocrinology and Metabolism, online erschienen am 24.09.2026. Verfasst von A. H. M. Shadequl Islam und 6 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Human leukocyte antigen (HLA) class II markers HLA-DR3 and HLA-DR4 are well-established genetic markers associated with autoimmune diabetes. However, data from Bangladesh are limited, especially in clinically heterogeneous young-onset diabetes.
Objective
To describe the frequencies of HLA-DR3 and HLA-DR4 positivity in Bangladeshi individuals with clinically heterogeneous young-onset diabetes and compare them with those of age- and sex-matched normoglycemic controls. Methodology: The current pilot case–control study recruited 35 young individuals with diabetes and 35 individuals (age- and sex-matched) with normal glucose tolerance (NGT). Clinical and anthropometric data were recorded. HLA-DR3 and HLA-DR4 positivity was detected by extraction of genomic DNA from peripheral blood, polymerase chain reaction, and gel electrophoresis.
Results
HLA-DR3 positivity was observed in 8.6% (3/35) of participants with diabetes and in none of the controls ( P = 0.239). HLA-DR4 positivity was detected in 22.9% (8/35) of the diabetes group and 28.6% (10/35) of controls ( P = 0.785). Within the diabetes group, no significant demographic, clinical, or biochemical differences were observed between participants who were positive for HLA-DR3/HLA-DR4 and those who were negative for both markers. Family history of diabetes ( P < 0.001) and acanthosis nigricans ( P = 0.031) were more common, and waist-to-hip ratio ( P = 0.007) and diastolic blood pressure ( P = 0.001) were higher in the diabetes group than in the NGT group.
Conclusions
In clinically heterogeneous young-onset diabetes in Bangladesh, broad HLA-DR3 and HLA-DR4 positivity did not differ significantly from those of normoglycemic controls. Further studies with refined phenotyping and higher-resolution immunogenetic assessment are required.
Zitieren
APA
Islam, A. H. M. S., Rahman, M. S., Hosen, M., Alam, M. J., Sultana, N., Hasan, M., & Hasanat, M. A. (2026). HLA-DR3 and HLA-DR4 Positivity in Young-Onset Diabetes in Bangladesh: A Pilot Case–Control Study. Bangladesh Journal of Endocrinology and Metabolism, 5(3), 320-327. https://doi.org/10.4103/bjem.bjem_32_26
Vancouver
Islam AHMS, Rahman MS, Hosen M, Alam MJ, Sultana N, Hasan M, et al. HLA-DR3 and HLA-DR4 Positivity in Young-Onset Diabetes in Bangladesh: A Pilot Case–Control Study. Bangladesh Journal of Endocrinology and Metabolism. 2026;5(3):320-327. doi:10.4103/bjem.bjem_32_26
BibTeX
@article{Islam2026,
author = {Islam, A. H. M. Shadequl and Rahman, Md. Saifur and Hosen, Mobarak and Alam, Mohammad Jahangir and Sultana, Nusrat and Hasan, Mashfiqul and Hasanat, Muhammad Abul},
title = {HLA-DR3 and HLA-DR4 Positivity in Young-Onset Diabetes in Bangladesh: A Pilot Case–Control Study},
journal = {Bangladesh Journal of Endocrinology and Metabolism},
year = {2026},
volume = {5},
number = {3},
pages = {320--327},
doi = {10.4103/bjem.bjem_32_26}
}
EUVIMED